|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization | |||||
| (Gain) loss on sale of business | |||||
| Deferred taxes | |||||
| Stock-based compensation expense | |||||
| Inventory and other non-cash charges | |||||
| Changes in operating assets and liabilities (net of effects of acquisitions and divestitures): | |||||
| Receivables | |||||
| Inventories | |||||
| Trade accounts payable | |||||
| Other assets and liabilities | |||||
| Foreign exchange and other operating activities, net | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities | |||||
| Capital expenditures | |||||
| Proceeds from sale of capital assets | |||||
| Acquisitions, net of cash acquired, and investments | |||||
| Proceeds from sale of business | |||||
| Other investing activities, net | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities | |||||
| Repayments of debt | |||||
| Proceeds from issuance of debt | |||||
| Payment of debt issuance costs | |||||
| Share repurchases | |||||
| Dividends paid | |||||
| Other financing activities, net | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | |||||
| Net Increase (Decrease) in Cash and Cash Equivalents | |||||
| Cash and Cash Equivalents at Beginning of Year | |||||
| Cash and Cash Equivalents at End of Year | |||||
Loading...